Cargando…

Survival and Release Behavior of a Novel Pre-, Pro-, and Postbiotic Capsule in an In Vitro SHIME Model

OBJECTIVES: To test the survival and release of probiotics (Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12), a prebiotic (bacteriophage blend), and a postbiotic (tributyrin) in a capsule-within-capsule design during passage through the gastrointestinal tract under fed an...

Descripción completa

Detalles Bibliográficos
Autores principales: Vance, Arianne, Raut, Shilpa, Grier-Welch, Adeline, Alamdari, Nima, Sharafi, Mastaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194016/
http://dx.doi.org/10.1093/cdn/nzac077.042
_version_ 1784726614619193344
author Vance, Arianne
Raut, Shilpa
Grier-Welch, Adeline
Alamdari, Nima
Sharafi, Mastaneh
author_facet Vance, Arianne
Raut, Shilpa
Grier-Welch, Adeline
Alamdari, Nima
Sharafi, Mastaneh
author_sort Vance, Arianne
collection PubMed
description OBJECTIVES: To test the survival and release of probiotics (Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12), a prebiotic (bacteriophage blend), and a postbiotic (tributyrin) in a capsule-within-capsule design during passage through the gastrointestinal tract under fed and fasted conditions. METHODS: Using an adapted Simulator of the Human Intestinal Microbial Ecosystem (SHIME®) model, physiological conditions of the stomach and small intestine, including pH profiles, temperature, incubation time, and addition of bile liquid and digestive enzymes, were simulated within the same reactor over time. The capsule contents included an inner capsule, containing probiotics and prebiotic phages, and an outer capsule, containing the postbiotic, with different delivery and release characteristics. Probiotic survival was assessed via plate counts and PMA-qPCR, release of phages was assessed via phage titer assay, and tributyrin release was assessed via gas chromatography. All experiments were performed in triplicate to account for biological variability. RESULTS: Under fasted conditions, the majority of the probiotics bypassed the stomach and small intestine in a viable form, of which more than 11 billion CFU were culturable. There were no significant differences between fasted and fed states. Similarly, the majority of the prebiotic phages survived transit through the stomach and small intestine. Tributyrin was mostly released in the small intestine. CONCLUSIONS: The capsule design ensured probiotics and prebiotic phages survived the harsh conditions of the upper gastrointestinal tract for delivery to the colon. The release of tributyrin within the small intestine supports its breakdown by pancreatic enzymes to produce short chain fatty acid butyrate. The findings of this study suggest a novel, colon-targeted probiotic delivery system explained by specific capsule and content characteristics. FUNDING SOURCES: The study was conducted by an independent lab, ProDigest, and funded and sponsored by Ritual (Natals, Inc.). Compound Solutions, Inc. also financially supported the study.
format Online
Article
Text
id pubmed-9194016
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91940162022-06-14 Survival and Release Behavior of a Novel Pre-, Pro-, and Postbiotic Capsule in an In Vitro SHIME Model Vance, Arianne Raut, Shilpa Grier-Welch, Adeline Alamdari, Nima Sharafi, Mastaneh Curr Dev Nutr Food Science and Nutrition OBJECTIVES: To test the survival and release of probiotics (Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12), a prebiotic (bacteriophage blend), and a postbiotic (tributyrin) in a capsule-within-capsule design during passage through the gastrointestinal tract under fed and fasted conditions. METHODS: Using an adapted Simulator of the Human Intestinal Microbial Ecosystem (SHIME®) model, physiological conditions of the stomach and small intestine, including pH profiles, temperature, incubation time, and addition of bile liquid and digestive enzymes, were simulated within the same reactor over time. The capsule contents included an inner capsule, containing probiotics and prebiotic phages, and an outer capsule, containing the postbiotic, with different delivery and release characteristics. Probiotic survival was assessed via plate counts and PMA-qPCR, release of phages was assessed via phage titer assay, and tributyrin release was assessed via gas chromatography. All experiments were performed in triplicate to account for biological variability. RESULTS: Under fasted conditions, the majority of the probiotics bypassed the stomach and small intestine in a viable form, of which more than 11 billion CFU were culturable. There were no significant differences between fasted and fed states. Similarly, the majority of the prebiotic phages survived transit through the stomach and small intestine. Tributyrin was mostly released in the small intestine. CONCLUSIONS: The capsule design ensured probiotics and prebiotic phages survived the harsh conditions of the upper gastrointestinal tract for delivery to the colon. The release of tributyrin within the small intestine supports its breakdown by pancreatic enzymes to produce short chain fatty acid butyrate. The findings of this study suggest a novel, colon-targeted probiotic delivery system explained by specific capsule and content characteristics. FUNDING SOURCES: The study was conducted by an independent lab, ProDigest, and funded and sponsored by Ritual (Natals, Inc.). Compound Solutions, Inc. also financially supported the study. Oxford University Press 2022-06-14 /pmc/articles/PMC9194016/ http://dx.doi.org/10.1093/cdn/nzac077.042 Text en © The Author 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Food Science and Nutrition
Vance, Arianne
Raut, Shilpa
Grier-Welch, Adeline
Alamdari, Nima
Sharafi, Mastaneh
Survival and Release Behavior of a Novel Pre-, Pro-, and Postbiotic Capsule in an In Vitro SHIME Model
title Survival and Release Behavior of a Novel Pre-, Pro-, and Postbiotic Capsule in an In Vitro SHIME Model
title_full Survival and Release Behavior of a Novel Pre-, Pro-, and Postbiotic Capsule in an In Vitro SHIME Model
title_fullStr Survival and Release Behavior of a Novel Pre-, Pro-, and Postbiotic Capsule in an In Vitro SHIME Model
title_full_unstemmed Survival and Release Behavior of a Novel Pre-, Pro-, and Postbiotic Capsule in an In Vitro SHIME Model
title_short Survival and Release Behavior of a Novel Pre-, Pro-, and Postbiotic Capsule in an In Vitro SHIME Model
title_sort survival and release behavior of a novel pre-, pro-, and postbiotic capsule in an in vitro shime model
topic Food Science and Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194016/
http://dx.doi.org/10.1093/cdn/nzac077.042
work_keys_str_mv AT vancearianne survivalandreleasebehaviorofanovelpreproandpostbioticcapsuleinaninvitroshimemodel
AT rautshilpa survivalandreleasebehaviorofanovelpreproandpostbioticcapsuleinaninvitroshimemodel
AT grierwelchadeline survivalandreleasebehaviorofanovelpreproandpostbioticcapsuleinaninvitroshimemodel
AT alamdarinima survivalandreleasebehaviorofanovelpreproandpostbioticcapsuleinaninvitroshimemodel
AT sharafimastaneh survivalandreleasebehaviorofanovelpreproandpostbioticcapsuleinaninvitroshimemodel